ALQAEM International to Make Noninvasive Glucose Monitor Available in the Region

DUBAI, United Arab Emirates, February 10, 2011 - The Health Care Division of ALQAEM International FZE, the
exclusive master distributor for the M.E.N.A. region of the UFIT(R)
noninvasive medical device created by Biosign Technologies Inc. of Canada, is
pleased to announce that it has placed orders for delivery this quarter and
will begin a limited release in March to those M.E.N.A. regions that
recognize the CE Mark for medical device registration.

ALQAEM and Biosign jointly announced the very successful
public debut of the UFIT(R) Heath Monitoring System at Arab Health 2011 in
Dubai, UAE (Jan 24th - 27th), where for the first time, the features and
benefits of the UFIT(R)TEN-20 non-invasive blood pressure and blood glucose
monitor were demonstrated to the public locally in the Gulf Region.

UFIT(R) TEN-20 is an online medical device for self-monitoring
of blood pressure and blood glucose. The device takes the pulse at the wrist
through an inflatable cuff and immediately produces pulse trace, blood
pressure and blood glucose measurement results. UFIT(R) TEN-20 does not
require any type of blood sampling or under-skin implant. All measurements
are indirect, noninvasive, and passive and do not produce any hazardous
waste. The results are stored on Biosign servers along with the digital test
sample. UFIT(R) TEN-20 is approved under ISO 13485 for the non-invasive
measurement of blood pressure and blood glucose, and carries the CE Mark.

John Rizvi, Managing Director of ALQAEM stated: "At Arab
Health 2011 we received a lot of attention from key government leaders and
retail partners from UAE, Saudi Arabia, Egypt and several other M.E.N.A.
countries. We will now launch this remarkable system to clinical and
institutional clients, which will tend to maximize the productivity of each
UFIT(R)PAD unit, and generate additional goodwill and media attention for
both ALQAEM and Biosign."

    Contact Information:
    ALQAEM International FZE
    (Healthcare Division)
    Mr. John Rizvi, Managing Director
    Phone: +971-6-557-8661
    Email: info@alqaemhealthcare.com
    Website: www.alqaemhealthcare.com

Contact Information: ALQAEM International FZE, (Healthcare Division), Mr. John Rizvi, Managing Director, Phone: +971-6-557-8661, Email: info at alqaemhealthcare.com